Scaling severe acute malnutrition treatment with community health workers: a geospatial coverage analysis in rural Mali.

BACKGROUND: In 2015, the Ministry of Health in Mali included the treatment of severe acute malnutrition (SAM) into the package of activities of the integrated Community Case Management (iCCM). This paper aims to analyze the impact of including community health workers (CHWs) as treatment providers outside the Health Facilities (HFs) on the coverage of SAM treatment when scaling up the intervention in the three largest districts of the Kayes Region in Mali. METHODS: A baseline coverage assessment was conducted in August 2017 in the three districts before the CHWs started treating SAM. The end-line assessment was conducted one year later, in August 2018. Coverage was assessed by the standardized methodology called Semi-Quantitative Evaluation of Access and Coverage (SQUEAC). The primary outcome was treatment coverage and other variables evaluated were the geographical distribution of the HFs, CHW's sites and overlapping between both health providers, the estimation of children with geographical access to health care and the estimation of children screened for acute malnutrition in their communities. RESULTS: Treatment coverage increased in Kayes (28.7-57.1%) and Bafoulabé (20.4-61.1%) but did not in Kita (28.4-28.5%). The decentralization of treatment has not had the same impact on coverage in all districts, with significant differences. The geospatial analyses showed that Kita had a high proportion of overlap between HFs and/or CHWs 48.7% (39.2-58.2), a high proportion of children without geographical access to health care 70.4% (70.1-70.6), and a high proportion of children not screened for SAM in their communities 52.2% (51.9-52.5). CONCLUSIONS: Working with CHWs in SAM increases treatment coverage, but other critical aspects need to be considered by policymakers if this intervention model is intended to be scaled up at the country level. To improve families' access to nutritional health care, before establishing decentralized treatment in a whole region it must be considered the geographical location of CHWs. This previous assessment will avoid overlap among health providers and ensure the coverage of all unserved areas according to their population densities need. TRIAL REGISTRATION: ISRCTN registry with ID 1990746. https://doi.org/10.1186/ISRCTN14990746.

A retrospective, observational study of perampanel in refractory and super-refractory status epilepticus.

INTRODUCTION: The outcomes of administration of Perampanel (PER) which is a ß-amino-3-(5-methyl-3-oxo-1,2-oxazol-4-yl)propionic acid (AMPA) receptor antagonist for the treatment of refractory status epilepticus (RSE) and Super-refractory (SRSE) were previously reported in small cohort studies and case reports. We report efficacy and side effect results of an observational cohort of 75 patients treated with PER for RSE and SRSE. METHODS: This was a single-center, retrospective, observational study of patients with RSE admitted to the neurocritical care unit between April 2017 and September 2019 who received treatment with PER. The primary outcome was the occurrence of a definite response to PER, which was defined as clear resolution of the ictal pattern and/or seizures within 72 h of delivery of PER which was the last administered antiseizure medication (ASM). Secondary outcomes included the percentage of patients other response types (partial responder or non-responder), as well as the rate of adverse effects. RESULTS: A total 75 patients were included in our analysis. PER was initiated as the median sixth ASM at a median initial dose of 12 mg. For the primary outcome, 31 (41.3%; 95% confidence interval 31.0%-53.0%) patients were classified as a definite responder. Seven patients (9.3%) experienced an adverse effect that was attributed to PER, with the most common being sedation in four patients. CONCLUSIONS: In our retrospective cohort of RSE, we observed a definite response rate of 41.3% within 72 h of PER initiation. PER was well tolerated with few documented adverse effects. Further prospective studies are needed to confirm the role of PER in treating patients with RSE.

Intravenous thrombolysis pretreatment and other predictors of infarct in a new previously unaffected territory (INT) in ELVO strokes treated with mechanical thrombectomy.

INTRODUCTION: One uncommon complication of mechanical thrombectomy (MT) is an infarct in a new previously unaffected territory (infarct in new territory (INT)). OBJECTIVE: To evaluate the predictors of INT with special focus on intravenous thrombolysis(IVT)pretreatmentbefore MT. METHODS: Consecutive patients with emergent large vessel occlusion (ELVO) treated with MT during a 5-year period were evaluated. INT was defined using standardized methodology proposed by ESCAPE investigators. The predictors of INT and its impact on outcomes were investigated. RESULTS: A total of 419 consecutive patients with ELVO received MT (mean age 64±15 years, 50% men, median baseline National Institutes of Health Stroke Scale score 16 points (IQR 11-20), 69% pretreated with IVT). The incidence of INT was lower in patients treated with combination therapy (IVTandMT) than in patients treated with MT alone, respectively (10% vs 20%; p=0.011). The INT group had more patients with posterior circulation occlusions than the group without INT (28% vs 10%, respectively; p<0.001). The rates of 3-month functional independence were lower in patients with INT (30% vs 50%; p=0.007). IVT pretreatment was not independently related to INT (OR=0.75; 95% CI 0.32 to 1.76), and INT did not emerge as an independent predictor of 3-month functional independence (OR=0.69; 95% CI 0.29 to 1.62) on multivariable logistic regression models. Location of posterior circulation occlusion was independently associated with a higher odds of INT (OR=3.33; 95% CI 1.43 to 7.69; p=0.005). CONCLUSIONS: IVT pretreatment is not independently associated with a lower likelihood of INT in patients with ELVO treated with MT. Patients with ELVO with posterior circulation occlusion are more likely to have INT after MT.

Frecuencia de parasitos intestinales y características epidemiológicas de la población infantil de 1 a 12 años que consulta al ambulatorio urbano tipo II de Cerro Gordo, Barquisimeto, estado Lara: enero-junio 2007 / Frequence of intestinal parasitism and epidemiological characteristics of the 1 to 12 year-old child population treated at the Cerro Gordo type II urban outpatient clinic, Barquisimeto, state Lara: january-june 2007

El objetivo de esta investigación fue determinar la frecuencia de parasitosis intestinales en el área de influencia del Ambulatorio Urbano Tipo II de Cerro Gordo, Barquisimeto, Estado Lara, realizando un estudio descriptivo transversal. Se evaluaron 106 niños entre 1 y 12 años de edad, realizando a cada uno examen de heces directo y concentrado con la técnica de Ritchie, demostrándo se parasitosis intestinal en 42,5%, predominando en escolares (48,9%), sin diferencias según el género. El agente más frecuente fue B. hominis (42,2%), seguido de G. lamblia (37,8%), Complejo Entamoeba histolytica/Entamoeba dispar (13,3%), H. nana (11,1%) y A. lumbricoides (4,4%). Se encontró parasitado 41,7% de niños con estado nutricional normal y 35,7% de malnutridos. La presencia de parasitos intestinales mostró relación con la disposición inadecuada de basura (p=0.048). El lavado inadecuado de las manos se relacionó con prurito anal (p=0.008). La calidad inadecuada del agua se relacionó con Blastocistosis (p= 0,025) y comensales (p= 0,035). No hubo relación entre parasitosis intestinales y síntomas gastrointestinales, estrato social, disposición de excretas, presencia de vectores en el hogar, lavado y conservación de alimentos, frecuencia de recolección de basura, lavado de manos, antecedente de tratamiento antiparasitario y familiar parasitado

A cross-sectional study was conducted to determine intestinal parasitism in children treated at the “Cerro Gordo” Type II Urban Outpatient Clinic in Barquisimeto, Lara. Feces samples were collected from 106 children (1-12 years old) and analyzed using both direct and Ritchie´s technique analyses, demonstrating intestinal parasitism in 42.5% of the children, predominantly of school age (48.9%), but independent of gender. The most frequent agent was Blastocystis hominis (42.2%), followed by Giardia lamblia (37.8%), Entamoeba histolytica/Entamoeba dispar Complex (13.3%), Hymenolepis nana (11.1%) and Ascaris lumbricoides (4.4%). For children with a normal nutritional condition, 41.7% had parasites, while this value was 35.7% for nutritionally undernourished children. The presence of intestinal parasites showed relations to the community’s trash collection management program status (p=0.048). Poor hand washing habits were significantly associated with anal pruritus (p=0.008). Inadequate water quality was related to blastocystosis (p= 0.025) and comensals (p= 0.035). The presence of parasites was not associated with specific gastrointestinal symptoms, socioeconomic status, disposition of excreta, presence of vectors in the home, food washing and storage, frequency of garbage collection, washing of hands, family parasitism history and anti-parasite treatment antecedents